European (EU) H2020 funded ORGANTRANS project is set to develop a disruptive solution that enables the 3D printing of tissue-engineered constructs. AMIRES, together with seven consortium members, coordinated by CSEM will create a standardized and automated tissue preparation and maturation platform, which will provide patients with End-Stage Liver Disease (ESLD) an alternative to donor organ transplants.
Read the CSEM press release announcing the kick-off of ORGANTRANS.
